Discharge Medication Use Post-Operatively in GU Cancer Patients

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Jan 24, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how much opioid medication patients use after having surgery for genitourinary cancers, like bladder, kidney, or prostate cancer. After surgeries such as cystectomy (removing the bladder), nephrectomy (removing the kidney), or prostatectomy (removing the prostate), participants will fill out a survey 30 days later to report their opioid use and how they disposed of any leftover medication. The study also aims to see if providing an educational pamphlet about safely disposing of unused opioids helps people manage their medications better.

To participate in this study, you must be at least 18 years old and scheduled for one of the listed surgeries due to a cancer diagnosis. You should be able to read and understand either English or Spanish and be willing to give consent for your health information to be used in the study. If you join, you can expect to share your experiences with pain management after surgery and learn about proper disposal methods for any leftover opioids, all while helping researchers gather important information that could improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Written informed consent and HIPAA authorization for release of personal health information.
• • 2. Age ≥ 18 years at the time of enrollment
• • 3. Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
• • 4. Ability to read and understand the English and/or Spanish language.
• • 5. Enrolling investigator plans to prescribe opioids at the time of discharge for post-operative pain.
• • 6. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.
• Exclusion Criteria:
• • None